ENDRA Life Sciences (Nasdaq: NDRA)’s Post

View profile for François Michelon, graphic

CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease

ENDRA's great sales team demonstrating our liver fat measurement technology at the UK Diabetes Professional Care conference. Liver fat is increasingly viewed as a primary biomarker of overall metabolic health. #endra #TAEUS #MASLD #diabetes

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics